NextCure, Inc. (NXTC)
7.055
-0.78
(-9.90%)
USD |
NASDAQ |
May 26, 16:00
7.02
-0.04
(-0.50%)
After-Hours: 20:00
NextCure EPS Diluted (Quarterly) : -1.870 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 0.0211 |
| Alnylam Pharmaceuticals, Inc. | 1.508 |
| Amgen, Inc. | 3.344 |
| Savara, Inc. | -0.1472 |
| Biogen, Inc. | 2.153 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -9.796M |
| Total Expenses (Quarterly) | 9.796M |
| Enterprise Value | -3.864M |
| Earnings Yield | -270.3% |
| Normalized Earnings Yield | -270.34 |